FDA Approves Unknown Drug — STRIDES PHARMA INTL

# FDA Approves Generic Drug Application for Strides Pharma International Strides Pharma International received FDA approval for ANDA062538 on April 7, 1986, expanding its portfolio of generic pharmaceutical offerings and positioning the company to capture market share in the competitive generics sector. The approval strengthens Strides Pharma's foothold in the U.S. pharmaceutical market during a period of growing demand for cost-effective generic alternatives.